NCT00025558View on ClinicalTrials.gov

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Primary Completion Date

May 31, 2007

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

temozolomide

DRUG

thiotepa

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (4)

6001

Princess Margaret Hospital for Children, Perth

10016

NYU Cancer Institute at New York University Medical Center, New York

19104

Children's Hospital of Philadelphia, Philadelphia

43205-2696

Columbus Children's Hospital, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00025558 - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer | Biotech Hunter | Biotech Hunter